Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2020-04-30

First triple combination therapy for asthma with optional electronic sensor

View source ↗

Summary

The European Medicines Agency announces the first triple combination therapy for asthma with an optional electronic sensor to monitor adherence and inhaler use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • triple combination therapy for asthma